​

LAVA Therapeutics (LVTX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

LAVA Therapeutics Revenue Highlights

Latest Revenue (Y)

$11.98M

Latest Revenue (Q)

$6.99M

Main Geography (Y)

Netherlands

LAVA Therapeutics Revenue by Period

LAVA Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$11.98M77.01%
2023-12-31$6.77M-65.09%
2022-12-31$19.39M262.45%
2021-12-31$5.35M42.78%
2020-12-31$3.75M100.00%
2019-12-31--

LAVA Therapeutics generated $11.98M in revenue during NA 2024, up 77.01% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

LAVA Therapeutics Revenue by Quarter

DateRevenueChange
2024-03-31$6.99M1880.74%
2023-12-31$353.00K566.04%
2023-09-30$53.00K-98.97%
2023-06-30$5.14M319.85%
2023-03-31$1.22M-53.64%
2022-12-31$2.64M-82.70%
2022-09-30$15.26M3160.90%
2022-06-30$468.00K-53.20%
2022-03-31$1.00M-
2021-12-31$1.00M-51.59%
2021-09-30$2.07M93.53%
2021-06-30$1.07M-1.13%
2021-03-31$1.08M-52.07%
2020-12-31$2.25M132.01%
2020-09-30$970.94K45.83%
2020-06-30$665.80K100.00%
2020-03-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--

LAVA Therapeutics generated $6.99M in revenue during Q1 2024, up 1880.74% compared to the previous quarter, and up 264.85% compared to the same period a year ago.

LAVA Therapeutics Revenue Breakdown

LAVA Therapeutics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24
Netherlands$11.98M

LAVA Therapeutics's latest annual revenue breakdown by geography, as of Dec 24: Netherlands (100.00%).

LAVA Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CCCCC4 Therapeutics$20.76M-
GBIOGeneration Bio$19.89M$4.09M
ADAGAdagene$18.11M$833.34K
LVTXLAVA Therapeutics$11.98M$6.99M
KRONKronos Bio$9.85M$2.37M
XLOXilio Therapeutics$6.34M$2.36M
IKNAIkena Oncology--
ANEBAnebulo Pharmaceuticals--
DSGNDesign Therapeutics--
RZLTRezolute--
ANTXAN2 Therapeutics--
ACHLAchilles Therapeutics--
EWTXEdgewise Therapeutics--
AVTEAerovate Therapeutics--
NXTCNextCure--
TILInstil Bio--
ASMBAssembly Biosciences-$6.84M
ERASErasca--
ACRVAcrivon Therapeutics--
PMVPPMV Pharmaceuticals--

LVTX Revenue FAQ

What is LAVA Therapeutics’s yearly revenue?

LAVA Therapeutics's yearly revenue for 2024 was $11.98M, representing an increase of 77.01% compared to 2023. The company's yearly revenue for 2023 was $6.77M, representing a decrease of -65.09% compared to 2022. LVTX's yearly revenue for 2022 was $19.39M, representing an increase of 262.45% compared to 2021.

What is LAVA Therapeutics’s quarterly revenue?

LAVA Therapeutics's quarterly revenue for Q1 2024 was $6.99M, a 1880.74% increase from the previous quarter (Q4 2023), and a 471.24% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $353K, a 566.04% increase from the previous quarter (Q3 2023), and a -86.63% decrease year-over-year (Q4 2022). LVTX's quarterly revenue for Q3 2023 was $53K, a -98.97% decrease from the previous quarter (Q2 2023), and a -99.65% decrease year-over-year (Q3 2022).

What is LAVA Therapeutics’s revenue growth rate?

LAVA Therapeutics's revenue growth rate for the last 3 years (2022-2024) was -38.21%, and for the last 5 years (2020-2024) was 219.78%.